Detecting cancers at an early stage is the best way to increase the chance of successful treatment.

This is the main aim of the breast and bowel cancer screening programmes. The aim of the cervical screening programme is to help prevent cervical cancers.

You can find links to information about the bowel cancer, breast cancer and cervical screening available on this web page, including links to information in Easy Read format.

We are committed to making reasonable adjustments to make sure everyone can access our services.  Visit NHS England: reasonable adjustments to find out more.

NHS population screening: information for trans and non-binary people is available on  www.gov.uk

Bowel cancer screening is offered to detect bowel cancer when it is at an early stage in people with no symptoms. This is when treatment is more likely to be effective. 

Screening can also find polyps. These are abnormal clumps of cells in the bowel. 

Polyps are not cancers but may develop into cancers over time. Polyps can be easily removed, which reduces the risk of bowel cancer developing.

The NHS offers screening to save lives from breast cancer. Screening does this by finding breast cancers at an early stage when they are too small to see or feel. Screening does not prevent you from getting breast cancer.

If you have missed your breast screening appointment, contact your area to arrange another, for

Ashford, Canterbury, Dover, Shepway and Thanet visit East Kent Hospitals University NHS Foundation Trust: breast screening (mammogram)

Maidstone, Tunbridge Wells and surrounding boroughs visit Maidstone and Tunbridge Wells NHS Trust: breast care unit

Dartford, Gravesham, Medway, Swanley and Swale visit Medway NHS Foundation Trust: breast care unit

NHS cervical screening helps prevent cervical cancer. It saves thousands of lives from cervical cancer each year in the UK.

In England, cervical screening currently prevents 70 per cent of cervical cancer deaths. If everyone eligible for screening attended screening regularly, 83 per cent could be prevented.

From 1 July 2025, individuals aged 25 to 49 who test negative for high-risk HPV will be invited for cervical screening every five years instead of every three.

This change reflects updated evidence showing that HPV-negative individuals are at very low risk of developing cervical cancer within that time.